Literature DB >> 8741127

Epidemiology of multiple sclerosis in the county of Vestfold, eastern Norway: incidence and prevalence calculations.

A Edland1, H Nyland, T Riise, J P Larsen.   

Abstract

The county of Vestfold in the South-eastern part of Norway has undergone two incidence and prevalence surveys on multiple sclerosis. The prevalence of definite/probable MS on January 1, 1963 was 61.6/100,000. Based on the same diagnostic criteria, the present study reports a slight increase in prevalence to 86.4/100,000 on January 1st 1983. The average annual incidence was calculated for 5 years periods from 1953 to 1983. The time periods 1953-1962 and 1973-1977 showed age-adjusted incidence rates between 4.50 and 5.49/100,000 while the 10-year period 1963-1972 showed significantly lower rates. The fluctuating pattern of MS incidence and prevalence over time supports the view that MS is not a stable disease, and that exogenous factors are influencing the disease pattern.

Entities:  

Mesh:

Year:  1996        PMID: 8741127     DOI: 10.1111/j.1600-0404.1996.tb00183.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Västerbotten County in northern Sweden.

Authors:  P Sundström; L Nyström; L Forsgren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.

Authors:  Seyed Aidin Sajedi; Fahimeh Abdollahi
Journal:  BMC Neurol       Date:  2012-09-24       Impact factor: 2.474

Review 3.  Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.

Authors:  N Grytten; Ø Torkildsen; K-M Myhr
Journal:  Acta Neurol Scand       Date:  2015       Impact factor: 3.209

4.  Multiple sclerosis in the far north--incidence and prevalence in Nordland County, Norway, 1970-2010.

Authors:  Espen Benjaminsen; Johnny Olavsen; Merethe Karlberg; Karl B Alstadhaug
Journal:  BMC Neurol       Date:  2014-12-04       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.